Update on the medical treatment of stable angina

Archives of Cardiovascular Diseases

Volumn 104, Issue 10, 2011, Pages 536-544

  Gayet, Jean Louis ^a   Paganelli, Franck ^b   Cohen Solal, Alain ^c  

^a Hôpital Nord ^*  (France)

^b HÔPITAL NORD   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Disease free survival; Drug therapy; Myocardial ischemia; Revascularization; Stable angina pectoris

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FELODIPINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISRADIPINE; IVABRADINE; MOLSIDOMINE; NICARDIPINE; NICORANDIL; NIFEDIPINE; NITRATE; RANOLAZINE; TRIMETAZIDINE; VERAPAMIL;

BRADYCARDIA; CONSTIPATION; CORONARY ARTERY DISEASE; DIET; DISEASE FREE SURVIVAL; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; HEADACHE; HEART FAILURE; HUMAN; LIFESTYLE MODIFICATION; NAUSEA; PARKINSONISM; PROGNOSIS; QT PROLONGATION; REVASCULARIZATION; REVIEW; STABLE ANGINA PECTORIS;

EID: 80255138087     PISSN: 18752136     EISSN: 18752128     Source Type: Journal    
DOI: 10.1016/j.acvd.2011.08.001     Document Type: Review

References (62)

1. Aouba A, Péquignot F, Le Toullec A, et al. Numéro thématique : surveillance épidémiologique des causes de décs en France. Les causes médicales de décs en France en 2004 et leur évolution 1980-2004. Accessed 9 February 2011. http://www.invs.sante.fr/beh/.
2. K. Fox, M.A. Garcia, and D. Ardissino Guidelines on the management of stable angina pectoris: executive summary. The task force on the management of stable angina pectoris of the European Society of Cardiology Eur Heart J 27 2006 1341 1381 (Pubitemid 43998110)
3. T.D. Fraker Jr., S.D. Fihn, and R.J. Gibbons 2007 chronic angina focused update of the ACC/AHA 2002. Guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to develop the focused update of the 2002. Guidelines for the management of patients with chronic stable angina Circulation 116 2007 2762 2772 (Pubitemid 350291248)
4. L. Lorgis, M. Zeller, and P. Jourdain Heart rate distribution and predictors of increased heart rate among French hypertensive patients with stable coronary artery disease. Data from the LHYCORNE cohort Arch Cardiovasc Dis 102 2009 541 547
5. J.Y. Tabet, M.C. Malergue, and M. Guenoun Distribution of left ventricular ejection fraction and heart rate values in a cohort of stable coronary patients: the INDYCE registry Arch Cardiovasc Dis 103 2010 354 362
6. A. Cassar, D.R. Holmes Jr., and C.S. Rihal Chronic coronary artery disease: diagnosis and management Mayo Clin Proc 84 2009 1130 1146
7. F. Eid, and W.E. Boden The evolving role of medical therapy for chronic stable angina Curr Cardiol Rep 10 2008 263 271
8. R. Kones Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization Vasc Health Risk Manag 6 2010 749 774
9. O'Toole L. Angina (chronic stable). Clin Evid (Online) 2008; 2008.
10. Palaniswamy C, Aronow WS. Treatment of stable angina pectoris. Am J Ther 2010.
11. M.E. Pfisterer, M.J. Zellweger, and B.J. Gersh Management of stable coronary artery disease Lancet 375 2010 763 772
12. W. Wijns, P. Kolh, and N. Danchin Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 31 2010 2501 2555
13. D.J. Maron, W.E. Boden, and R.A. O'Rourke Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial J Am Coll Cardiol 55 2010 1348 1358
14. W.E. Boden, R.A. O'Rourke, and K.K. Teo Optimal medical therapy with or without PCI for stable coronary disease N Engl J Med 356 2007 1503 1516 (Pubitemid 46588415)
15. D.J. Cohen, J.P. Carrozza, and D.S. Baim Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease N Engl J Med 341 1999 1853 1854 [author reply 54-55]
16. W. Hueb, N. Lopes, and B.J. Gersh Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease Circulation 122 2010 949 957
17. R.L. Frye, P. August, and M.M. Brooks A randomized trial of therapies for type 2 diabetes and coronary artery disease N Engl J Med 360 2009 2503 2515
18. M.L. Simoons, and S. Windecker Controversies in cardiovascular medicine: chronic stable coronary artery disease: drugs vs. revascularization Eur Heart J 31 2010 530 541
19. M. Lievre, and M. Cucherat Aspirin in the secondary prevention of cardiovascular disease: an update of the APTC meta-analysis Fundam Clin Pharmacol 24 2010 385 391
20. P. Henry, A. Vermillet, and B. Boval Twenty four-hour time-dependent aspirin efficacy in patients with stable coronary artery disease Thromb Haemost 105 2011 336 344
21. A.Y. Gasparyan Aspirin and clopidogrel resistance: methodological challenges and opportunities Vasc Health Risk Manag 6 2010 109 112
22. C. Baigent, L. Blackwell, and J. Emberson Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomized trials Lancet 376 2010 1670 1681
23. J.E. Deanfield, P. Sellier, and E. Thaulow Potent anti-ischaemic effects of statins in chronic stable angina: incremental benefit beyond lipid lowering? Eur Heart J 31 2010 2650 2659
24. S. Yusuf, P. Sleight, and J. Pogue Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153
25. K.M. Fox Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomized, double-blind, placebo-controlled, multicentre trial (the EUROPA study) Lancet 362 2003 782 788 (Pubitemid 37093919)
26. N. Freemantle, J. Cleland, and P. Young Beta blockade after myocardial infarction: systematic review and meta regression analysis BMJ 318 1999 1730 1737 (Pubitemid 29290470)
27. P.H. Stone, N.A. Gratsiansky, and A. Blokhin Antianginal efficacy of ranolazine when added to treatment with amlodipine: the Efficacy of Ranolazine in Chronic Angina (ERICA) trial J Am Coll Cardiol 48 2006 566 575 (Pubitemid 44093970)
28. P.A. Poole-Wilson, J. Lubsen, and B.A. Kirwan Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomized controlled trial Lancet 364 2004 849 857
29. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomized trial. Lancet 2002; 359:1269-75.
30. N. Danchin, M. Angioi, and J.P. Preiss Beta-blocker therapy in acute myocardial infarction Arch Mal Coeur Vaiss 91 Spec No. 2 1998 43 47 (Pubitemid 28208070)
31. J.D. Parker, and J.O. Parker Nitrate therapy for stable angina pectoris N Engl J Med 338 1998 520 531 (Pubitemid 28103137)
32. E. Tadamura, M. Mamede, and S. Kubo The effect of nitroglycerin on myocardial blood flow in various segments characterized by rest-redistribution thallium SPECT J Nucl Med 44 2003 745 751 (Pubitemid 39655209)
33. J. Abrams Nitroglycerin and long-acting nitrates in clinical practice Am J Med 74 1983 85 94 (Pubitemid 13064824)
34. U. Thadani Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina and heart failure Cardiovasc Drugs Ther 10 1997 735 742 (Pubitemid 27129777)
35. C.C. Carson 3rd Cardiac safety in clinical trials of phosphodiesterase 5 inhibitors Am J Cardiol 96 2005 37M 41M
36. A.H. Gomma, H.J. Purcell, and K.M. Fox Potassium channel openers in myocardial ischaemia: therapeutic potential of nicorandil Drugs 61 2001 1705 1710 (Pubitemid 32980502)
37. A. Markham, G.L. Plosker, and K.L. Goa Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects Drugs 60 2000 955 974
38. W.C. Stanley, and M. Marzilli Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine Fundam Clin Pharmacol 17 2003 133 145 (Pubitemid 36513204)
39. Ciapponi A, Pizarro R, Harrison J. Trimetazidine for stable angina. Cochrane Database Syst Rev 2005:CD003614.
40. Commission nationale de pharmacovigilance. Compte rendu de la réunion du mardi 19 mai 2009. Accessed 4 July 2011. http://www.afssaps. fr/var/afssaps-site/storage/original/application/ 61c6847bb097168d0bfe266d5515ec7b.pdf.
41. Réunion de la Commission d'AMM du 7 avril 2011. Accessed 4 July 2011. http://www.afssaps.fr/Activites/Expertise/Commissions-et-groupes-de- travail/Commission-d-autorisation-de-mise-sur-le-marche/Reunion-de-la- commission-d-AMM-du-07-avril-2011/(language)/fre-FR.
42. J.S. Borer, K. Fox, and P. Jaillon Antianginal and anti-ischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial Circulation 107 2003 817 823
43. J.C. Tardif, I. Ford, and M. Tendera Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina Eur Heart J 26 2005 2529 2536 (Pubitemid 41677303)
44. J.C. Tardif, P. Ponikowski, and T. Kahan Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial Eur Heart J 30 2009 540 548
45. K. Fox, I. Ford, and P.G. Steg Ivabradine for patients with stable coronary artery disease and left ventricular systolic dysfunction (BEAUTIFUL): a randomized, double-blind, placebo-controlled trial Lancet 372 2008 807 816
46. C. Thollon, and J.P. Vilaine I(f) inhibition in cardiovascular diseases Adv Pharmacol 59 2010 53 92
47. G.C. Demontis, C. Gargini, and T.G. Paoli Selective Hcn1 channels inhibition by ivabradine in mouse rod photoreceptors Invest Ophthalmol Vis Sci 50 2009 1948 1955
48. P.P. Dobesh, and T.C. Trujillo Ranolazine: a new option in the management of chronic stable angina Pharmacotherapy 27 2007 1659 1676 (Pubitemid 350234315)
49. D.T. Nash, and S.D. Nash Ranolazine for chronic stable angina Lancet 372 2008 1335 1341
50. D.S. Vadnais, and N.K. Wenger Emerging clinical role of ranolazine in the management of angina Ther Clin Risk Manag 6 2010 517 530
51. B.R. Chaitman, C.J. Pepine, and J.O. Parker Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial JAMA 291 2004 309 316 (Pubitemid 38101603)
52. B.R. Chaitman, S.L. Skettino, and J.O. Parker Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina J Am Coll Cardiol 43 2004 1375 1382 (Pubitemid 38496341)
53. S.R. Wilson, B.M. Scirica, and E. Braunwald Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes (MERLIN-TIMI) 36 Trial J Am Coll Cardiol 53 2009 1510 1516
54. Haute Autorité de santé. Commisssion de transparence du 4 novembre 2009. Accessed 4 July 2011. http://www.has-sante.fr/portail/upload/ docs/application/pdf/2009-11/ranexa ct-6981.pdf.
55. M.D. Beaulieu, R. Blais, and A. Jacques Are patients suffering from stable angina receiving optimal medical treatment? QJM 94 2001 301 308 (Pubitemid 32600489)
56. F.C. Wiest, C.L. Bryson, and M. Burman Suboptimal pharmacotherapeutic management of chronic stable angina in the primary care setting Am J Med 117 2004 234 241 (Pubitemid 39092716)
57. C. Daly, F. Clemens, and J.L. Lopez-Sendon The impact of guideline compliant medical therapy on clinical outcome in patients with stable angina: findings from the Euro Heart Survey of stable angina Eur Heart J 27 2006 1298 1304 (Pubitemid 43998102)
58. D.H. Elder, M. Pauriah, and C.C. Lang Is there a Failure to Optimize theRapy in anGina pEcToris (FORGET) study? QJM 103 2010 305 310
59. K. Fox, I. Ford, and P.G. Steg Heart rate as a prognostic risk factor in patients with coronary artery disease and left ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomized controlled trial Lancet 372 2008 817 821
60. S. Bangalore, J. Qin, and S. Sloan What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial Circulation 122 2010 2142 2151
61. S.J. Denardo, F.H. Messerli, and E. Gaxiola Coronary revascularization strategy and outcomes according to blood pressure (from the International Verapamil SR-Trandolapril Study [INVEST]) Am J Cardiol 106 2010 498 503
62. Haute Autorité de santé. Guide affection de longue durée. Maladie coronarienne. Accessed 9 February 2010. http://www.has-sante.fr/portail/jcms/c-534304/ald-n13-maladie-coronarienne.